a public good project by the
Synthesis
Company
of California

© 2026

David Kerr | doi.page

0 works0 citations0 h-index

David Kerr

Sutter Health(US)Nuffield Orthopaedic Centre(GB)University of Oxford(GB)

Publications by Year

Research Areas

Genetic factors in colorectal cancer, Colorectal Cancer Treatments and Studies, Cancer Genomics and Diagnostics, Colorectal Cancer Surgical Treatments, Colorectal Cancer Screening and Detection

Most-Cited Works

→ A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer(2004)2,690 cited
→ International network of cancer genome projects(2010)2,399 cited
→ COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study(2020)1,140 cited
→ Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas(2012)998 cited
→ A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21(2007)807 cited
→ Delivering affordable cancer care in high-income countries(2011)709 cited

→ Disease-Free Survival Versus Overall Survival As a Primary End Point for Adjuvant Colon Cancer Studies: Individual Patient Data From 20,898 Patients on 18 Randomized Trials(2005)

706 cited

→ Value of Mismatch Repair, KRAS , and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer(2011)675 cited

→ Influence of Resection Margins on Survival for Patients With Pancreatic Cancer Treated by Adjuvant Chemoradiation and/or Chemotherapy in the ESPAC-1 Randomized Controlled Trial(2001)629 cited

→ COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study(2020)599 cited